Original Research

Published on 04 Jul 2024

Relationship between cathepsins and cardiovascular diseases: a Mendelian randomized study

in Cardiovascular and Smooth Muscle Pharmacology

Qiaoqiao Li
Zhongzheng Zhou
Teng Xu
Xueping Gao
Yake Lou
Zijun Chen
Muzi Zhang
Qinghua Fang
Jie Tan
Jing Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370350

1,668 views

Original Research

Published on 04 Jul 2024

Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia

in Cardiovascular and Smooth Muscle Pharmacology

Denisa Miklankova
Irena Markova
Martina Hüttl
Hana Malinska

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393946

1,201 views

Mini Review

Published on 27 Jun 2024

Role of EZH2-mediated epigenetic modification on vascular smooth muscle in cardiovascular diseases: A mini-review

in Cardiovascular and Smooth Muscle Pharmacology

Haiyan Luo
Yao Li
Honghu Song
Kui Zhao
Wenlin Li
Hailan Hong
Yun-Ting Wang
Luming Qi
Yang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1416992

1,611 views
8 citations

Review

Published on 26 Jun 2024

An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity

in Cardiovascular and Smooth Muscle Pharmacology

Sicong Xie
Yuwei Sun
Xuan Zhao
Yiqun Xiao
Fei Zhou
Liang Lin
Wei Wang
Bin Lin
Zun Wang
Zixuan Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406247

2,044 views
2 citations

Original Research

Published on 25 Jun 2024

β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Xun-Hu Gu
Weichao Li
Heng Li
Xun Guo
Jiang He
Yuyan Liu
Jianping Gong
Yizhou Huang
Bin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418465

1,186 views

Original Research

Published on 20 Jun 2024

CaMKIIδ-dependent dysregulation of atrial Na+ homeostasis promotes pro-arrhythmic activity in an obstructive sleep apnea mouse model

in Cardiovascular and Smooth Muscle Pharmacology

Philipp Hegner
Florian Ofner
Benedikt Schaner
Mathias Gugg
Maximilian Trum
Anna-Maria Lauerer
Lars Siegfried Maier
Michael Arzt
Simon Lebek
Stefan Wagner

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411822

974 views

Original Research

Published on 20 Jun 2024

Suppression by central adenosine A3 receptors of the cholinergic defense against cardiovascular aberrations of sepsis: role of PI3K/MAPKs/NFκB signaling

in Cardiovascular and Smooth Muscle Pharmacology

Amany E. El-Naggar
Mai M. Helmy
Sahar M. El-Gowilly
Mahmoud M. El-Mas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418981

1,030 views

Correction

Published on 18 Jun 2024

Corrigendum: Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery

in Cardiovascular and Smooth Muscle Pharmacology

Kuang-Ming Liao
Chuan-Wei Shen
Yun-Hui Huang
Chun-Hui Lu
Hsuan-Lin Lai
Chung-Yu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438588

442 views

Review

Published on 17 Jun 2024

Non-human primate studies for cardiomyocyte transplantation—ready for translation?

in Cardiovascular and Smooth Muscle Pharmacology

Constantin von Bibra
Rabea Hinkel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1408679

1,318 views

Review

Published on 14 Jun 2024

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects

in Cardiovascular and Smooth Muscle Pharmacology

Maria Antonietta Riemma
Elena Mele
Maria Donniacuo
Marialucia Telesca
Gabriella Bellocchio
Giuseppe Castaldo
Francesco Rossi
Antonella De Angelis
Donato Cappetta
Konrad Urbanek

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422740

2,310 views
1 citation

Original Research

Published on 13 Jun 2024

Addition of eptifibatide and manual thrombus aspiration to ticagrelor does not improve long-term survival after STEMI treated with primary PCI

in Cardiovascular and Smooth Muscle Pharmacology

Paul-Adrian Călburean
Paul Grebenișan
Ioana-Andreea Nistor
Krisztina Pal
Victor Vacariu
Reka-Katalin Drincal
Alissa Anamaria Ion
István Adorján
Tiberiu Oltean
László Hadadi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415025

857 views
1 citation

Review

Published on 13 Jun 2024

Dialogue between mitochondria and endoplasmic reticulum-potential therapeutic targets for age-related cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Chen Chen
Xueyan Dong
Wang Zhang
Xing Chang
Wulin Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389202

1,875 views
1 citation

Original Research

Published on 12 Jun 2024

Efficacy and safety of rivaroxaban versus warfarin in the management of unusual site deep vein thrombosis: a retrospective cohort study

in Cardiovascular and Smooth Muscle Pharmacology

Linlin Fu
Wenting Cai
Hanyang Li
Dan Han
Li Li
Baoyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419985

1,073 views

Review

Published on 11 Jun 2024

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome

in Cardiovascular and Smooth Muscle Pharmacology

Wei-Dong Sun
Xiao-Juan Zhu
Jing-Jing Li
Ya-Zhong Mei
Wen-Song Li
Jiang-Hua Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410479

2,608 views
3 citations

Mini Review

Published on 10 Jun 2024

PDE4 inhibitors: potential protective effects in inflammation and vascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Tianfei Fan
Wenjing Wang
Yao Wang
Mingtang Zeng
Yi Liu
Shuyao Zhu
Lin Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407871

2,904 views
2 citations

Review

Published on 05 Jun 2024

Inhibition of differentiation of monocyte-derived macrophages toward an M2-Like phenotype May Be a neglected mechanism of β-AR receptor blocker therapy for atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Shouyi Liu
Bo Zhang
Jingqun Zhou
Jianfeng Lv
Jinxia Zhang
Xiangyan Li
Weihua Yang
Yuanlin Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378787

976 views

Navigation group

Articles

Relationship between cathepsins and cardiovascular diseases: a Mendelian randomized study

Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia

Role of EZH2-mediated epigenetic modification on vascular smooth muscle in cardiovascular diseases: A mini-review

An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity

β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseases

CaMKIIδ-dependent dysregulation of atrial Na+ homeostasis promotes pro-arrhythmic activity in an obstructive sleep apnea mouse model

Suppression by central adenosine A3 receptors of the cholinergic defense against cardiovascular aberrations of sepsis: role of PI3K/MAPKs/NFκB signaling

Corrigendum: Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery

Non-human primate studies for cardiomyocyte transplantation—ready for translation?

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects

Addition of eptifibatide and manual thrombus aspiration to ticagrelor does not improve long-term survival after STEMI treated with primary PCI

Dialogue between mitochondria and endoplasmic reticulum-potential therapeutic targets for age-related cardiovascular diseases

Efficacy and safety of rivaroxaban versus warfarin in the management of unusual site deep vein thrombosis: a retrospective cohort study

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome

PDE4 inhibitors: potential protective effects in inflammation and vascular diseases

Inhibition of differentiation of monocyte-derived macrophages toward an M2-Like phenotype May Be a neglected mechanism of β-AR receptor blocker therapy for atherosclerosis